CH5126766 suppressed not only BRAF, but also CRAF kinase activity, and we conclude that CH5126766 is an attractive RAF/MEK inhibitor in RAS-mutated malignant tumor cells including melanoma. The gene discussed is RAF1; the disease is melanoma.